The US Food and Drug Administration approved the revised label for inclisiran, a small interfering RNA that reduces the ...

The document was designed to promote standardization and identify future research goals in this rapidly-growing field.

Boston Scientific is recommending updates to the instructions for use to minimize the issue, which has been tied to 17 deaths ...